FOXO4-DRI: research, legal status and who sells it

This page is information, not medical advice. FOXO4-DRI is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Also known as
FOXO4 D-retro-inverso peptide
Category
Experimental senolytic peptide
Evidence level
Preclinical (lab and animal studies)
Price range
$11.25/mg to $31.98/mg, median $20.85/mg across 16 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNo FDA-approved drug contains FOXO4-DRI [1].
United KingdomNo UK-licensed medicine containing FOXO4-DRI appears in the MHRA products database [2].
European UnionNo medicine containing FOXO4-DRI is authorized in the EU, according to EMA's central and Article 57 product data [3][4].
CanadaNo product containing FOXO4-DRI appears in Health Canada's Drug Product Database [5].
AustraliaFOXO4-DRI is not named in Australia's Poisons Standard (October 2026) [6].
Sport (WADA)Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7].
Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of FOXO4-DRI yet. The legal status table and live prices on this page are current.

FOXO4-DRI prices: cheapest listings

The five lowest $/mg listings out of 21. See all FOXO4-DRI prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Premier Bio Labs 72/100 FOXO4 (10mg) 10 mg $85 $8.50/mg −59% Out of stock View
Peptide Crafters 27/100* FOXO4-DRI (12mg) 12 mg $135 $11.25/mg −46% In stock View
Licensed Peptides 62/100 FOXO4-DRI 10mg 10 mg × 10 $1,140 $11.40/mg −45% Out of stock View
Ion Peptide 25/100* FOXO4-DRI – 10mg 10 mg $119 $11.90/mg −43% In stock View
NuLife Peptides 10/100* FOXO4-DRI (10mg) 10 mg $125 $12.50/mg −40% In stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. A transparency score marked * is based on fewer than six checks; checks we couldn't complete score 0. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
  2. MHRA Products: licensed-medicine search for "foxo4". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
  3. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
  4. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
  5. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
  6. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
  7. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026